Format

Send to

Choose Destination
Best Pract Res Clin Rheumatol. 2002 Apr;16(2):281-91.

Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis.

Author information

1
Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, Medical Education Building, Room 609, 1813 Sixth Avenue South, 35294, USA.

Abstract

Infections are one of the leading causes of morbidity and mortality in patients with systemic lupus erythematosus (SLE). Therapeutic, disease-related and genetic factors all contribute to a lupus patient's increased susceptibility to infections. Although bacterial pathogens are the most common cause of infections, a wide variety of pathogens have been reported. In high-risk populations, identification and treatment of chronic infections such as tuberculosis, hepatitis B or human immunodeficiency virus, are important prior to the institution of immunosuppression to prevent reactivation or exacerbation of the infection. Judicious use of corticosteroids and cytotoxic drugs is critical in limiting infectious complications. Vaccines against influenza and pneumococcus appear to be safe and immunogenic in SLE patients and their routine administration should be encouraged.

PMID:
12041954
DOI:
10.1053/berh.2001.0226
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center